← SynDRA

DACLATASVIR

SynDRA canonical compound SYN0029157 — structure-anchored drug synonym record

All known targets

• HCV NS5A
• KCNH2
• NS5A

Mechanisms of action (all sources)

• HCV inhibitor
• Inhibitor

Drug classes

• P-Glycoprotein Inhibitors
• Organic Anion Transporting Polypeptide 1B1 Inhibitors
• Organic Anion Transporting Polypeptide 1B3 Inhibitors
• Breast Cancer Resistance Protein Inhibitors
• Hepatitis C Virus NS5A Inhibitor

ATC classes

• J05A · DIRECT ACTING ANTIVIRALS

Cross-references

• PubChem CID: 25154714
• ChEMBL: CHEMBL2023898
• DrugBank: DB09102
• ChEBI: CHEBI:83800
• KEGG: D10065
• Wikipedia: Daclatasvir
• TTD: D09SGV

Synonyms

• daclatasvir dihydrochloride
• daclatasvir hydrochloride
• daklinza
• BMS-790052-05
• BMS-790052
• daclatasvir HCl
• daclatasivr
• EBP-883
• Daclatasvir (BMS-790052)
• CHEBI:82977
• C40H50N8O6
• methyl N-[(1S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate
• Daclatasvir (USAN)
• cc-39
• Daclatasvir BMS 790052
• MLS006011140
• SCHEMBL2756027
• CHEMBL2023898
• SCHEMBL17897804
• KS-00000XPC
• EX-A410
• BMS 790052
• Daklinza
• BMS790052
• Daclatasvir [USAN]
• Daclatasvir dihydrochloride
• methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
• Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester
• Carbamic acid, N,N'-((1,1'-biphenyl)-4,4'-diylbis(1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,C'-dimethyl ester
• Dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dica
• methyl N-[(2S)-1-[(2S)-2-[5-(4'-{2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl}-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
• LI2427F9CI
• DACLATASVIR [MI]
• DACLATASVIR [INN]
• DACLATASVIR [WHO-DD]
• dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate
• EBP883
• GTPL11266